Earnings Preview: HealthStream

HealthStream (NASDAQ:HSTM) is set to give its latest quarterly earnings report on Monday, 2023-10-23. Here’s what investors need…

HealthStream (NASDAQ:HSTM) is set to give its latest quarterly earnings report on Monday, 2023-10-23. Here’s what investors need to know before the announcement.

Analysts estimate that HealthStream will report an earnings per share (EPS) of $0.09.

HealthStream bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.04, which was followed by a 1.21% drop in the share price the next day.

Here’s a look at HealthStream’s past performance and the resulting price change:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate 0.09 0.08 0.05 0.05
EPS Actual 0.13 0.12 0.08 0.05
Price Change % -1.21% -7.28% 4.85% 5.33%

eps graph

Stock Performance

Shares of HealthStream were trading at $22.34 as of October 19. Over the last 52-week period, shares are up 2.99%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for HealthStream visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

IM Cannabis’ Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in revenue to CA$48.8 million ($36 million) in 2023. IM Cannabis attributed it to "negative currency fluctuations and the impact of the Israel-Hamas war on the company's operations." Fourth quarter revenue dropped 26% year-over-year to CA$10.7 million. "As previously warned and as expected, unfortunately, the Israel-Hamas war had a negative impact on our fourth quarter 2023 results, which weighed on our full-year results.," Uri Birenberg, chief financial officer of IMC, said. "Coupled with our fourth quarter of 2023 inventory reduction, the war caused our fourth quarter gross profit to decrease by 68% as compared to the fourth quarter of 2022."

CSE:IMCC